
Bayer and Vividion to Showcase Oncology Advances at AACR 2025
Bayer and Vividion to Showcase Oncology Advances at AACR 2025 Bayer and Vividion Therapeutics, Inc. (Vividion), a wholly owned subsidiary of Bayer AG, are set to present groundbreaking research from their oncology pipelines at the American Association for Cancer Research…